Speeding therapies to market requires more than faster development; it demands a smarter regulatory strategy. This eBook explores how life sciences organizations are leveraging expedited regulatory pathways, reliance procedures and global regulatory collaborations to accelerate approvals while maintaining regulatory rigor. Learn how FDA, EMA and PMDA accelerated pathways are being used in practice, how reliance models and consortia initiatives can support global submissions, and why regulatory intelligence is critical for navigating evolving requirements and bringing innovative therapies to patients faster.

Fix formatting issues in Word documents and reduce rework across your team.

OnStyle combines structured authoring, configurable standards, and automated validation.

Fix formatting issues in Word documents and reduce rework across your team.

OnStyle combines structured authoring, configurable standards, and automated validation.

Fix formatting issues in Word documents and reduce rework across your team.

OnStyle combines structured authoring, configurable standards, and automated validation.

Inconsistent formatting, hidden errors, and manual checks cost time, create rework, and increase risk.
OnStyle automatically identifies and fixes formatting issues in Word, while enforcing your standards in the background.

Less rework. Faster approvals. More compliant documents.

All too often documents are formatted inconsistently and contain errors. Your team follows standards—but enforcing them costs time, rework, and approvals... Until now. Meet OnStyle. OnStyle automatically identifies and corrects issues in Word documents. And, when creating new documents, it helps by applying standard styles and formatting rules... Reduce risks, speed up your  process, and create compliant documents. Try OnStyle for free and claim your 26% discount while available.

Most pharma organizations continue to face persistent challenges in shortening submission timelines.

Read this whitepaper to discover how an AI-first, structured content authoring solution can help you create data-centric documentation:

• Slash authoring times, create first-time-right drafts faster with GenAI
• Enable efficient document lifecycle management with automated content reuse
• Keep track of the regulatory submissions process by automating complex data analysis
• Accelerate global submissions with faster translation and localization
• Achieve predictive compliance by forecasting regulatory changes that need to be implemented
• Deploy a single solution for the creation, management and publication of  dossiers
• Innovate with confidence and win the race

The decentralised procedure (DCP) is the European Union-wide procedure for authorising medicines in more than one European Union Member State in parallel. It can be used for medicines that do not need to be authorised via the centralised procedure and have not already been authorised in any Member State. The procedure falls under the Directive 2004/27/EC.

In the decentralised procedure, the applicant chooses one country as the reference Member State when making its application for marketing authorisation. The marketing authorisation in all chosen Member States is received simultaneously, enabling simultaneous marketing of the medicine and reducing the administrative and regulatory burden.

Access a comprehensive overview of our company through our Corporate Presentation. This document provides detailed insights into our mission, vision, and values, along with an overview of our core business areas, growth strategies, recent achievements, and future outlook.

Designed to offer a clear and concise perspective of who we are, what we do, and how we create value for our clients, partners, this presentation serves as an essential resource for understanding our organization.

Download it now to learn more about our value proposition, our team, and the opportunities we are driving.

A small biotech needed an informed consent form (ICF) for an IND submission, with limited lead time following agency feedback. The challenge was compounded by a lack of prior materials and an untested template.

Synterex’s Solution:
AgileWriter™ was pretrained using draft sources and updated incrementally as new protocol information became available. The model’s output was so robust it was also leveraged to produce a pregnant partner ICF for the same study.

A medium-sized biotech faced a tight deadline: a comprehensive Clinical Study Report (CSR) shell and first draft were needed in just two weeks, compared to the industry norm of six or more. The project was further complicated by complex oncology study design and data in less-than-ideal formats.

Synterex’s Solution:
Leveraging AgileWriter™, Synterex trained an AI model in real time, mapping planned content to a CSR template and SDTM datasets. As new information arrived, the model was incrementally refined, with a medical writer overseeing the process to ensure quality and compliance.

Digital tools in pharmacovigilance are increasingly valued for their transformative potential. Integrating these tools requires a strategic approach merging technological capability with regulatory compliance.

Evernorth® Health Services, collaborating with a contract research organization (CRO), performed direct-to-patient outreach to recruit patients for a pediatric vaccine trial to support a pharmaceutical sponsor. An incredible 700,000+ eligible patients within the age range were initially identified. After applying advanced analytics to narrow down to those most likely to qualify, households with multiple children were consolidated to maximize outreach efficacy.

Discover how a pharmaceutical company leveraged advanced analytics to streamline site selection for a Phase III oncology trial, ensuring efficient patient recruitment and high-quality data collection. Learn how integrating patient demographics, investigator profiles, and social determinants of health can enhance trial outcomes and accelerate drug development.

Discover groundbreaking insights into migraine prevalence, treatment variations, and healthcare provider dynamics with the PurpleLab Migraine Study. This comprehensive whitepaper leverages real-world data to illuminate the complexities of migraine management, offering valuable intelligence for healthcare providers and life sciences companies.

Life sciences companies are operating in a new world, one where new treatments are being developed at breakneck speed, which holds unprecedented promise for patients. However, this new world is also one that requires the use of real world data (RWD) to empower marketing teams to effectively engage with various stakeholders – and ultimately lead healthcare providers to prescribe innovative drugs to the patients who will truly benefit from these treatment therapies.

Analyzing real-world data (RWD) in pharmaceutical marketing has the power to unearth hidden trends and insights into the overall prescription landscape. However, accessing and compiling this data tends to be a resource-intensive process. This case study explores how PurpleLab’s Prescription Measurement Report empowered the marketing agency Deerfield to harness RWD insights effectively.

The pharmaceutical industry is evolving rapidly, but inefficient research workflows can slow innovation. With scientific literature growing exponentially and regulatory compliance becoming more demanding, AI is emerging as a transformative tool. 

This white paper explores how AI-driven solutions can streamline literature reviews, accelerate drug discovery, and enhance compliance, ultimately reducing time-to-market for critical breakthroughs. Learn how AI can automate tedious processes, improve data management, and provide real-time insights—allowing researchers to focus on what truly matters: advancing medicine. Dive in and discover the future of pharmaceutical research!

Introducing Literature Review by ReadCube

Systematic Literature Reviews (SLRs) help researchers and organizations navigate the growing sea of academic knowledge. Yet, traditional SLRs are slow, costly, and error-prone due to fragmented workflows.

What if you could transform your SLR process?

In The Future of Systematic Literature Reviews white paper, ReadCube introduces an AI-driven solution that streamlines workflows, reducing costs and improving accuracy. Discover the challenges of traditional reviews, the role of AI and automation, and how an all-in-one platform saves time and enhances efficiency.

Don't rely on outdated methods—download the white paper now!

Moderna, a leading mRNA technology company, saw unprecedented growth during the COVID-19 pandemic. Before this, its Medical Affairs teams aligned Research and Commercial narratives via a scientific communications platform (SCP) set annually with little change.

During the pandemic, daily data on the virus, its evolution, vulnerable populations, efficacy, durability, and real-world evidence (RWE) surged, overwhelming existing tools.

This case study explores how Moderna Medical Affairs used ReadCube’s platform as a centralized repository for efficient content management and integration, enhancing research accuracy, data efficiency, and collaboration.

Prior to the FD&C Act, pharmaceutical companies were not required to provide proof of drug safety or a disclosure of all active ingredients. Since then, all new drugs undergo an intensive review process by the Food and Drug Administration (FDA), and ever-evolving guidance and regulations ensure that both new drugs and those with updated characteristics, such as dosing, delivery, and expanded indications, are safe and effective for the intended populations. A gap remains, however, for drug investigations including and targeted for children of varying ages.

Download and read now for more insights!

Innovative development of human drugs, biologics, and medical devices (medical products) and their quick advancement through the United States Food and Drug Administration (FDA) approval pipeline is necessary to improve the lives of patients. It is also imperative for sponsors to consider diversity when enrolling study participants throughout the clinical development pipeline to adequately represent the population of patients who have a disease or condition.

Download and read now for more insights!

HALOPV - transforming the management of the Pharmacovigilance System Master File (PSMF)

The PSMF document is a compulsory and vital part of pharmacovigilance compliance in Europe, supporting and documenting a company’s compliance with the requirements laid down in EU legislation. Each pharma company has to have such a file, fully describing their PV system. It must be kept up to date and must be available within seven days on request if the EMA wishes to view it. As well as describing the company’s PV system, the PSMF includes annexes with up-to-date information on topics such as ongoing and completed clinical trials, registered products and audits.

The PSMF holds a large amount of important information and the variety of the information included means that all the information is rarely managed by the QPPV themselves, who maintains oversight and is responsible for the PSMF itself. The content might be provided by different personnel, from regulatory affairs, quality assurance or clinical development. Therefore, it is essential that the communication between these personnel and the QPPV is as seamless and transparent as possible.

Reducing the need for manual effort

The coordination of the material required for the PSMF used to be a highly manual endeavour. People would work with document management systems and the QPPV Office would have to manage multiple email exchanges and spreadsheets, in order to track who was providing what information and what had been sent through, then chasing what was needed. They then had to create a common format for all the information received so it could all be pulled together cohesively. Companies are updating this information at least on a quarterly basis and the bigger the company, the bigger the headache to collate everything correctly and on time.However, the technology used and developed for Insife’s revolutionary HALOPV system has now automated this process, saving effort, time and therefore money.

Templated for ease and consistency

The data sent through each annex is of course from different sources and systems, but HALOPV has an interface with other systems which identifies and uploads just the information that is needed, yet again eliminating excessive manual work. There are also templates for each annex so that once all the information has been uploaded from the different sources, it is all presented with the same look and feel. This makes it much easier to have a full oversight of all the content and be able to review it as needed.

All the annexes in the PSMF can be auto-scheduled, with notifications being sent out directly to the responsible person for each section of content. The system can also take away the need for ongoing manual tracking and follow up, with reminders being sent out automatically too. Based on our experience, the man hours saved can be substantial.

 It all starts with implementation

The key to a successful use of the PSMF module is the detailed work undertaken at implementation. Agreeing on the annexes and who will deliver the content for each is of course essential. While the QPPV is the person responsible for the PSMF, the responsibility of maintaining it may be delegated to a member of the QPPV Office. This depends on the size of the company and its internal structure.

The structure and working practices of each company also means that certain things in the Insife system need to be adaptable. There are templated workflows within the PSMF module, but they can be configured differently to make the module work in the most efficient way for each and every client.

The other crucial part of the implementation is of course the decisions on where the data are coming from and in what format. It could be emanating from five or six different IT systems in different departments, so agreement on formatting is key at this stage.

The future - globalising the PSMF

The EU’s PSMF legislation was set in 2010 and there are moves to create similar processes globally. Already, the UK (post Brexit), Turkey, India and Saudi Arabia have implemented their own requirements and others are following. There are challenges when looking at local and regional requirements as the varying regulations undoubtedly lead to logistical challenges. Insife are jumping to this challenge by providing options to create similar solutions for other countries. The key is to create rules that determine when the same information is required for other territories, so that replication of information is minimised and key data are shared as necessary.

HALOPV – the solution for future proofing your PSMF!

With the proven technology at the heart of HALOPV and the success of the PSMF module, Insife is in a perfect position to work with companies and regulators alike, to make the PSMF as seamless and efficient as possible, right across the globe.